首页> 美国卫生研究院文献>other >Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes
【2h】

Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes

机译:表面活性剂对预填充注射器抗体制剂中颗粒生成的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Protein aggregation and particle formation have been observed when protein solutions contact hydrophobic interfaces, and it has been suggested that this undesirable phenomenon may be initiated by interfacial adsorption and subsequent gelation of the protein. The addition of surfactants, such as polysorbate 20, to protein formulations has been proposed as a way to reduce protein adsorption at silicone oil-water interfaces and mitigate the production of aggregates and particles. In an accelerated stability study, monoclonal antibody formulations containing varying concentrations of polysorbate 20 were incubated and agitated in pre-filled glass syringes (PFS), exposing the protein to silicone oil-water interfaces at the siliconized syringe walls, air-water interfaces, and agitation stress. Following agitation in siliconized syringes that contained an air bubble, lower particle concentrations were measured in the surfactant-containing antibody formulations than in surfactant-free formulations. Polysorbate 20 reduced particle formation when added at concentrations above or below the critical micelle concentration (CMC). The ability of polysorbate 20 to decrease particle generation in PFS corresponded with its ability to inhibit gelation of the adsorbed protein layer, which was assessed by measuring the interfacial diffusion of individual antibody molecules at the silicone oil-water interface using total internal reflectance fluorescence (TIRF) microscopy with single-molecule tracking.
机译:当蛋白质溶液接触疏水界面时,已经观察到蛋白质聚集和颗粒形成,并且已经表明这种不良现象可能是由于蛋白质的界面吸附和随后的凝胶化而引发的。已经提出在蛋白质制剂中添加表面活性剂,例如聚山梨酯20,以减少在硅油-水界面处的蛋白质吸附并减轻聚集物和颗粒的产生。在加速稳定性研究中,将含有不同浓度的聚山梨酯20的单克隆抗体制剂在预填充的玻璃注射器(PFS)中温育和搅动,使蛋白质暴露于硅化注射器壁,空气-水界面和硅油-水界面之间。激动压力。在包含气泡的硅化注射器中搅拌后,与不含表面活性剂的制剂相比,含表面活性剂的抗体制剂中的颗粒浓度更低。当以高于或低于临界胶束浓度(CMC)的浓度添加时,聚山梨酯20减少了颗粒形成。聚山梨酯20减少PFS中颗粒生成的能力与其抑制吸附的蛋白质层胶凝的能力相对应,这是通过使用全内反射荧光(TIRF)测量硅油与水界面上单个抗体分子的界面扩散来评估的)单分子跟踪显微镜。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号